[(4E,6E,8S,9S,10E,12S,13R,14S,16R)-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(methylamino)-3,20,22-trioxo-13-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate

C32H46N4O7 — CID 15222136

IUPAC[(4E,6E,8S,9S,10E,12S,13R,14S,16R)-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(methylamino)-3,20,22-trioxo-13-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate
SMILESC=CCN[C@H]1[C@@H](OC)C[C@H](C)CC2=C(NC)C(=O)C=C(NC(=O)/C(C)=C/C=C/[C@H](OC)[C@@H](OC(N)=O)/C(C)=C/[C@@H]1C)C2=O
InChIInChI=1S/C32H46N4O7/c1-9-13-35-27-20(4)16-21(5)30(43-32(33)40)25(41-7)12-10-11-19(3)31(39)36-23-17-24(37)28(34-6)22(29(23)38)14-18(2)15-26(27)42-8/h9-12,16-18,20,25-27,30,34-35H,1,13-15H2,2-8H3,(H2,33,40)(H,36,39)/b12-10+,19-11+,21-16+/t18-,20+,25+,26+,27-,30+/m1/s1
InChIKeyPXTHPOSHGUWCRC-LTVCSCKSSA-N
MW598.74 g/mol
LogP2.76
Rot. Bonds7

About [(4E,6E,8S,9S,10E,12S,13R,14S,16R)-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(methylamino)-3,20,22-trioxo-13-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate

[(4E,6E,8S,9S,10E,12S,13R,14S,16R)-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(methylamino)-3,20,22-trioxo-13-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate (PubChem CID 15222136) has the molecular formula C32H46N4O7 and a molecular weight of 598.74 g/mol. Its IUPAC name is [(4E,6E,8S,9S,10E,12S,13R,14S,16R)-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(methylamino)-3,20,22-trioxo-13-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate.

Molecular Properties

Compound Name[(4E,6E,8S,9S,10E,12S,13R,14S,16R)-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(methylamino)-3,20,22-trioxo-13-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate
PubChem CID15222136
Molecular FormulaC32H46N4O7
Molecular Weight598.74 g/mol
Exact Mass598.34
IUPAC Name[(4E,6E,8S,9S,10E,12S,13R,14S,16R)-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(methylamino)-3,20,22-trioxo-13-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate
SMILESC=CCN[C@H]1[C@@H](OC)C[C@H](C)CC2=C(NC)C(=O)C=C(NC(=O)/C(C)=C/C=C/[C@H](OC)[C@@H](OC(N)=O)/C(C)=C/[C@@H]1C)C2=O
InChIInChI=1S/C32H46N4O7/c1-9-13-35-27-20(4)16-21(5)30(43-32(33)40)25(41-7)12-10-11-19(3)31(39)36-23-17-24(37)28(34-6)22(29(23)38)14-18(2)15-26(27)42-8/h9-12,16-18,20,25-27,30,34-35H,1,13-15H2,2-8H3,(H2,33,40)(H,36,39)/b12-10+,19-11+,21-16+/t18-,20+,25+,26+,27-,30+/m1/s1
InChIKeyPXTHPOSHGUWCRC-LTVCSCKSSA-N
XLogP2.76
TPSA158.08 Ų
H-Bond Donors4
H-Bond Acceptors9
Rotatable Bonds7
Heavy Atoms43
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500598.74
LogP ≤ 52.76
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'quinone_A(370)', 'substructure': 'N/A'}, {'alert_name': 'chinone_1', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [(4E,6E,8S,9S,10E,12S,13R,14S,16R)-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(methylamino)-3,20,22-trioxo-13-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(4E,6E,8S,9S,10E,12S,13R,14S,16R)-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(methylamino)-3,20,22-trioxo-13-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate?
The IUPAC name of [(4E,6E,8S,9S,10E,12S,13R,14S,16R)-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(methylamino)-3,20,22-trioxo-13-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate (CID 15222136) is [(4E,6E,8S,9S,10E,12S,13R,14S,16R)-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(methylamino)-3,20,22-trioxo-13-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate.
What is the SMILES notation for [(4E,6E,8S,9S,10E,12S,13R,14S,16R)-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(methylamino)-3,20,22-trioxo-13-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate?
The canonical SMILES for [(4E,6E,8S,9S,10E,12S,13R,14S,16R)-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(methylamino)-3,20,22-trioxo-13-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate is C=CCN[C@H]1[C@@H](OC)C[C@H](C)CC2=C(NC)C(=O)C=C(NC(=O)/C(C)=C/C=C/[C@H](OC)[C@@H](OC(N)=O)/C(C)=C/[C@@H]1C)C2=O.
What is the InChIKey of [(4E,6E,8S,9S,10E,12S,13R,14S,16R)-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(methylamino)-3,20,22-trioxo-13-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate?
The InChIKey is PXTHPOSHGUWCRC-LTVCSCKSSA-N. The full InChI is InChI=1S/C32H46N4O7/c1-9-13-35-27-20(4)16-21(5)30(43-32(33)40)25(41-7)12-10-11-19(3)31(39)36-23-17-24(37)28(34-6)22(29(23)38)14-18(2)15-26(27)42-8/h9-12,16-18,20,25-27,30,34-35H,1,13-15H2,2-8H3,(H2,33,40)(H,36,39)/b12-10+,19-11+,21-16+/t18-,20+,25+,26+,27-,30+/m1/s1.
What are the key properties of [(4E,6E,8S,9S,10E,12S,13R,14S,16R)-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(methylamino)-3,20,22-trioxo-13-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate?
[(4E,6E,8S,9S,10E,12S,13R,14S,16R)-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(methylamino)-3,20,22-trioxo-13-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate has a molecular weight of 598.74 g/mol, XLogP of 2.76, 7 rotatable bonds, 4 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for [(4E,6E,8S,9S,10E,12S,13R,14S,16R)-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(methylamino)-3,20,22-trioxo-13-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate is sourced from PubChem (CID 15222136), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).